Snowball logo
logo
MDBI_logo

Medibio Limited

MDBIF • PINK
$0.0071$0.00  (0%)
Estimate
EPS
-0.65
Beta
1.043
Growth
Net income, YoY
-4,843.5%
About the company
Ticker
MDBIF
ISIN
Country
Australia
Sector (GICS)
Healthcare
TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.

Frequently asked questions

What sector does Medibio Limited (MDBIF) operate in?

Medibio Limited belongs to the Healthcare sector and operates in the Health Information Services industry.

What is Medibio Limited (MDBIF) current stock price?

As of the latest data, Medibio Limited stock price is $0.01, with a previous close of $0.01.

What is Medibio Limited (MDBIF) current market capitalization?

Medibio Limited market cap is approximately 8.19 million.

What is Medibio Limited (MDBIF) Earnings Per Share (EPS)?

The trailing EPS is -$0.65.

What is Medibio Limited (MDBIF) EBITDA?

Medibio Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -714.90 thousand.

Does Medibio Limited (MDBIF) pay dividends?

No. Medibio Limited does not pay a dividend.

What is Medibio Limited (MDBIF) beta (volatility) score?

Medibio Limited has a beta of 1.043, meaning its volatility is roughly in line with the market.